Onco-Innovations Limited (CVE:ONCO) | WebDisclosure

Basculer en Français

10069	Companies
205843	Keywords
136106	Articles
109146	Press releases

Headlines Articles Press releases Onco-Innovations Limited

Home
Companies
Onco-Innovations Limited

PRESS RELEASE

published on 07/12/2025 at 00:00, 8 months 11 days ago

Onco-Innovations Signs Agreement with Redwood AI to Advance Discovery and Evaluation of Its PNKP Inhibitor Technology
Onco-Innovations partners with Redwood AI for drug development, leveraging AI-driven chemistry tools to enhance cancer therapy with PNKP Compound. Vancouver-based collaboration aims to improve research efficiency

Cancer Therapy Onco-Innovations PNKP Compound Redwood AI AI-driven Chemistry
BRIEF

published on 07/11/2025 at 00:05, 8 months 12 days ago

Onco-Innovations nomme le Dr Islam Mohamed à la présidence de son conseil consultatif

Biotechnologie Conseil Consultatif Oncologie Recherche Sur Le Cancer Dr Islam Mohamed
BRIEF

published on 07/11/2025 at 00:05, 8 months 12 days ago

Onco-Innovations Appoints Dr. Islam Mohamed as Advisory Board Chair

Biotechnology Advisory Board Oncology Cancer Research Dr. Islam Mohamed
PRESS RELEASE

published on 07/11/2025 at 00:00, 8 months 12 days ago

Onco-Innovations Strengthens Clinical Leadership with Appointment of Dr. Islam Mohamed as Advisory Board Chair
Onco-Innovations Limited appoints Dr. Islam Mohamed as Chair of Scientific and Clinical Advisory Board, highlighting commitment to oncology research excellence and innovation acceleration

Scientific Advisory Board Oncology Research Onco-Innovations Limited Dr. Islam Mohamed Clinical Advisory Board
BRIEF

published on 07/05/2025 at 00:05, 8 months 18 days ago

Onco-Innovations s'associe à Nucro-Technics pour des études précliniques

Traitement Du Cancer Etudes Précliniques Onco-Innovations Nucro-Techniques Inhibiteur De La PNKP
BRIEF

published on 07/05/2025 at 00:05, 8 months 18 days ago

Onco-Innovations Partners with Nucro-Technics for Preclinical Studies

Cancer Treatment Preclinical Studies Onco-Innovations PNKP Inhibitor Nucro-Technics
PRESS RELEASE

published on 07/05/2025 at 00:00, 8 months 18 days ago

Onco-Innovations Enters Agreement with Nucro-Technics for IND-Enabling Studies, Taking a Key Step Toward Human Trials
Onco-Innovations partners with Nucro-Technics for preclinical studies on PNKP inhibitor, critical step towards human trials. Strategic collaboration with GLP and GMP experienced CRO

Clinical Trials Preclinical Studies Onco-Innovations PNKP Inhibitor Nucro-Technics
BRIEF

published on 07/03/2025 at 00:35, 8 months 20 days ago

Onco-Innovations dévoile ses développements stratégiques lors d'une conférence téléphonique avec les investisseurs

Intelligence Artificielle Traitement Du Cancer Étapes Stratégiques Onco-Innovations Inhibiteur De PNKP
BRIEF

published on 07/03/2025 at 00:35, 8 months 20 days ago

Onco-Innovations Reveals Strategic Developments in Investor Call

Artificial Intelligence Cancer Treatment Strategic Milestones Onco-Innovations PNKP Inhibitor
PRESS RELEASE

published on 07/03/2025 at 00:30, 8 months 20 days ago

Onco-Innovations CEO Highlights Strategic Milestones and R&D Progress in Special Investors' Conference Call
Onco-Innovations updates strategic roadmap for cancer treatment innovation, highlighting AI partnerships and research collaborations

Cancer Treatment Strategic Roadmap AI Partnerships Onco-Innovations Research Collaborations

Accesswire

Published on 03/23/2026 at 22:00, 13 minutes ago

Hillcrest Participates in APEC 2026 and Announces Shares for Debt Offering
Published on 03/23/2026 at 21:18, 55 minutes ago

Amdocs Announces Appointment of Shimie Hortig to the Board of Directors Upon Shuky Sheffer's Retirement as Director and Chief Executive Officer
Published on 03/23/2026 at 14:05, 8 hours 8 minutes ago

Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Published on 03/23/2026 at 14:00, 8 hours 13 minutes ago

BlackBerry AtHoc Advances Command Center for Faster Response and Tighter Control During Critical Operations
Published on 03/23/2026 at 13:05, 9 hours 8 minutes ago

SouthGobi Announces Disclosable and Connected Transaction Deferral of Payment Obligations Under Convertible Debenture and Amended and Restated Cooperation Agreement

View all ACCESSWIRE

EQS Group

Published on 03/23/2026 at 22:05, 8 minutes ago

DeFi Technologies Provides Update on Timing of Annual Filings
Published on 03/23/2026 at 21:05, 1 hour 8 minutes ago

Abivax annonce ses résultats financiers pour l’exercice 2025 et fait le point sur l’avancement de ses activités
Published on 03/23/2026 at 21:05, 1 hour 8 minutes ago

Abivax Announces Full Year 2025 Financial Results and Provides Business Updates
Published on 03/23/2026 at 21:00, 1 hour 13 minutes ago

Persistent Appoints Ruchi Kulhari as Executive Vice President - Enterprise Strategy & Execution
Published on 03/23/2026 at 20:55, 1 hour 18 minutes ago

Ordering Both ESR and CRP Lab Tests Could Save Hospitals Millions Per Year -- New Study Challenges Notion the Tests are Interchangeable

Les Echos

Published on 03/23/2026 at 19:08, 3 hours 5 minutes ago

Reporting on share buyback transactions carried out between March 16 and March 20, 2026
Published on 03/23/2026 at 19:08, 3 hours 5 minutes ago

Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 16 et le 20 mars 2026
Published on 03/23/2026 at 18:37, 3 hours 36 minutes ago

ALTAREA : Déclaration d’opérations sur actions propres
Published on 03/23/2026 at 17:45, 4 hours 28 minutes ago

ENGIE will build, own and operate its largest onshore wind farm worldwide in Egypt
Published on 03/23/2026 at 17:45, 4 hours 28 minutes ago

En Égypte, ENGIE va construire et exploiter son plus grand parc éolien terrestre au monde

View all LES ECHOS COMFI WIRE